Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Perrigo Company plc (PRGO)

  • Business News
  • Nov. 05, 2025, 11:35 UTC
  • 11
  • 1 comments

Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations

Market reaction Comment Full text

Bio-Techne Corp (TECH)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 13
  • 1 comments

BIO-TECHNE DECLARES DIVIDEND

Market reaction Comment Full text

COMPASS Pathways plc (CMPS)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 11
  • 1 comments

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Market reaction Comment Full text

AmerisourceBergen (ABC)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 13
  • 1 comments

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Market reaction Comment Full text

Cencora INC (COR)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 13
  • 1 comments

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Market reaction Comment Full text

Recursion Pharmaceuticals Inc (RXRX)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 13
  • 1 comments

Recursion Reports Third Quarter 2025 Financial Results and Provides Business Update

Market reaction Comment Full text

Ocugen Inc. (OCGN)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 10
  • 1 comments

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

Market reaction Comment Full text

Fortrea Holdings Inc (FTRE)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 10
  • 1 comments

Fortrea Reports Third Quarter 2025 Results

Market reaction Comment Full text

Perrigo Company plc (PRGO)

  • Business News
  • Nov. 05, 2025, 11:30 UTC
  • 11
  • 1 comments

Perrigo to Conduct Strategic Review of its Infant Formula Business

Market reaction Comment Full text

Recursion Pharmaceuticals Inc (RXRX)

  • Business News
  • Nov. 05, 2025, 11:28 UTC
  • 13
  • 1 comments

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

Market reaction Comment Full text
  • Previous
  • 844
  • 845
  • 846
  • 847
  • 848
  • Next

Search

News categories

  • Technical Exchange News(10979)
  • Event(2471)
  • SEC News(194284)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126386)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin